Covance

Description

As the drug development business of Laboratory Corporation of America Holdings (Labcorp) and the world’s most comprehensive drug development #CRO service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.

Headquarters:
United States

Pharmaceuticals, Research

Speciaties:

Drug Development Services Toxicology Services Central Laboratory Services Clinical Trial Management Services Clinical Research Phase I-IIa Phase II-III Preclinical Solutions Cardiovascular Oncology Rare and Orphan Disease Market Access Food Solutions Rare Disease Orphan Drugs Biotech Pharmaceuticals Crop Protection Clinical Trial Optimization Clinical Trials Biologics Cell and Gene Therapy Pharmacovigilance NASH Infectious Diseases Drug Testing CRO Immuno-Oncology Commercialization Pediatrics Kidney Disease Inflammation Life Sciences Bioassays Bioanalysis Large Molecule Small Molecule

View Employees

Chris Hansen
Solutions Architect at Covance
Rhoda Miller
ITC Project Specialist at Covance
Marcia Rexroat
Quality Assurance at Covance
Kayla Fowler
Clinical Research Associate 2 at Covance
Robert Murphy
Senior Business Relationship Manager at Covance
Karen Gaughan
Senior Project Manager at Covance
Honggang Bi
Corporate VP, General Manager China at Covance
Lukas Vaclavik
Senior Scientist at Covance
Young-Kook Kim
Senior Clinical Research Associate at Covance Korea, CRO
Arshad Keloth
Talent Acquisition Manager at Covance (LabCorp)

Find more contacts